Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Accenture plc Chair and CEO Julie Sweet reported multiple open-market sales of Class A ordinary shares. On February 3, 2026, she sold several blocks of stock at weighted average prices ranging from $238.9284 to $249.7469 under a pre-arranged Rule 10b5-1 trading plan.
After these transactions, Sweet directly beneficially owned 21,150 Class A ordinary shares of Accenture. The prices for each sale reflect weighted averages of numerous individual trades within the stated price ranges.
Accenture plc Chief Accounting Officer Melissa A. Burgum reported a small planned stock sale. On 02/03/2026, she sold 15 Class A ordinary shares at $250.43 per share under a Rule 10b5-1 trading plan. After this transaction, she beneficially owned 8,033 shares directly.
Accenture plc Chief Strategy & Services Officer Manish Sharma reported a small, planned stock sale. On February 3, 2026, he sold 98 Class A ordinary shares at $250.36 per share in a transaction coded as a sale.
The filing notes this was a planned disposition under a Rule 10b5-1 trading plan, meaning the trade was scheduled in advance. After this transaction, Sharma directly owns 5,031 Class A ordinary shares of Accenture.
Accenture insider plans a small share sale under Rule 144. A person named John F. Walsh has filed to sell 14 Class A Ordinary shares of Accenture through UBS Financial Services on the NYSE, with an approximate sale date of February 4, 2026. These shares were acquired as a stock award from the issuer on February 1, 2026. The filing also shows that Walsh sold 3,986 Class A Ordinary shares in a prior transaction on January 27, 2026, generating gross proceeds of $1,101,644.30.
Accenture plc executive Manish Sharma reported a disposition of 1,928 Class A ordinary shares. The transaction occurred on February 1, 2026 at a reported price of $262.22 per share under transaction code F. Following this event, Sharma beneficially owns 5,129 Class A shares directly.
Accenture plc Chair and CEO Julie Spellman Sweet, who also serves as a director, reported a disposition of 10,696 Class A ordinary shares on February 1, 2026 at a price of $262.22 per share. Following this transaction, she directly beneficially owned 26,650 Class A ordinary shares of Accenture.
Accenture plc executive Melissa A. Burgum reported a small share disposition. As Chief Accounting Officer, she reported the disposition of 131 Class A ordinary shares on February 1, 2026 at a price of $262.22 per share. Following this transaction, she directly beneficially owned 8,048 Class A ordinary shares.
Accenture plc Chief Financial Officer trades company stock
Accenture plc Chief Financial Officer Angie Y. Park reported a disposition of 602 Class A ordinary shares on February 1, 2026 at a price of $262.22 per share. After this transaction, Park beneficially owned 12,378 Class A ordinary shares directly.
Accenture plc CEO-The Americas John F. Walsh reported a disposition of Class A ordinary shares. On February 1, 2026, a transaction coded “F” involved 2,235 Class A ordinary shares at $262.22 per share. After this transaction, he directly beneficially owned 24,986 Class A ordinary shares.
Accenture plc executive Mauro Macchi, Chief Executive Officer-EMEA, reported a disposition of Class A ordinary shares. On 02/01/2026, he disposed of 1,755 shares at $262.22 per share, a transaction coded “F.” Following this, he directly beneficially owns 5,368 Class A ordinary shares.